1 / 4

Asia-Pacific COVID-19 Diagnostics Market Size, Share, Impressive Industry Growth

Asia-Pacific COVID-19 Diagnostics Market is estimated to reach around $3.3 billion in 2027, by growing at a CAGR of -21.6% during the forecast period (2021-2027).

globalomr
Download Presentation

Asia-Pacific COVID-19 Diagnostics Market Size, Share, Impressive Industry Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Asia-Pacific COVID-19 Diagnostics Market: Analysis Report, Share, Trends and Overview 2021-2027 Request https://www.omrglobal.com/request-sample/asia-pacific-covid-19-diagnostics-market a sample of our report on Asia-Pacific COVID-19 Diagnostics Market: ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 7803040404

  2. Asia-Pacific COVID-19 Diagnostics Market is estimated to reach around $3.3 billion in 2027, by growing at a CAGR of -21.6% during the forecast period (2021-2027). Asia-Pacific COVID-19 diagnostics market has been growing at a rapid pace owing to significantly growing screening test in the emerging economies such as India, China, Japan, and rest of Asia-Pacific countries. China was the first economy that was severely hit by COVID-19 as the country was the epicenter of the COVID-19. The market in the region is mainly growing due to the introduction of various advanced and early detection diagnostics kits in the region. (Get 15% Discount on Buying this Report) A https://www.omrglobal.com/industry-reports/asia-pacific-covid-19-diagnostics-market full report of Asia-Pacific COVID-19 Diagnostics Market is available at: Government Packages for COVID-19 On 19the April 2020, Government of Japan passed an emergency budget worth around $240 billion, comprising cash handouts for every resident, to fight with the economic devastation formed by the COVID-19 outbreak. The budget also includes money to boost the production of masks for medical workers, improve COVID-19 testing capacity, and support the acceleration of drug and vaccine development. As of 30th April 2020, according to the International Monetary Fund (IMF), an estimated $367 billion in fiscal measures or financing have been announced to fight the virus. The package includes increase epidemic prevention spending, production of medical equipment, moving up unemployment payments and social security tax relief. To learn more about this report request a sample copy @ https://www.omrglobal.com/request- sample/asia-pacific-covid-19-diagnostics-market Scope of the Asia-Pacific COVID-19 Diagnostics Market Market Coverage Market number available - 2020-2027 Base year- 2020 Forecast period- 2021-2027 Segment Covered- By Type, Technology and End user Countries Covered- China, Japan, India, and Rest of Asia-Pacific Competitive Landscape-BGI Group, Mylab Discovery Solutions Pvt Ltd., Sansure Biotech Inc., Seegene Inc., and ADT Biotech Sdn Bhd.

  3. Recent Strategic Initiatives in the Asia-Pacific COVID-19 DiagnosticsMarket In July 2020, Mylab launched its Compact XL, claimed by the company as the country’s first machine to automatize the diagnostics manual processes of molecular diagnostics including RT-PCR tests for COVID-19. Compact XL is a cartridge-based machine that is capable of testing many samples at a time. In May 2020, Mylab Discovery Solutions expanded its production capacity to manufacture COVID-19 RT-PCR tests. As per the production plan, Mylab is scaling-up manufacturing to 2 lakh tests per day. As of May 2020, the company has already manufactured 6.5 lakh tests and has supplied tests to 140 sites including labs and hospitals in more than 20 states of India. Asia-Pacific COVID-19 Diagnostics Market-Segmentation By Technology Polymerase Chain Reaction (PCR) Antibody or Enzyme-Linked Immunosorbent Assay (ELISA) Serology By Type Instruments Reagents & Kits By End user Hospitals Diagnostic Centers & Urgent Care Clinics Research Labs For more customized data, request for report customization @ https://www.omrglobal.com/report- customization/asia-pacific-covid-19-diagnostics-market Asia-Pacific COVID-19 DiagnosticsMarket– Segment by Country China Japan India Rest of Asia-Pacific

  4. Company Profiles BGI Group Mylab Discovery Solutions Pvt Ltd. Sansure Biotech Inc. Seegene Inc. ADT Biotech Sdn Bhd Seegene Inc. Sysmex Corp. Veredus Laboratories Pte Ltd. CPC Diagnostics Pvt. Ltd. Guangzhou Wondfo Biotech Co., Ltd. J Mitra & Co. Pvt Ltd. Reasons to Buying From us – 1.We cover more than 15 major industries, further segmented into more than 90 sectors. 2.More than 120 countries are for analysis. 3.Over 100+ paid data sources mined for investigation. 4.Our expert research analysts answer all your questions before and after purchasing your report. About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 7803-040-404

More Related